Bias shown in reporting efficacy and toxicity in breast cancer trialsStudy also revealed poor reporting of toxicity, particularly for breast cancer studies with positive primary endpoints. Beware the shrinking penisResearchers raise awareness of a little-known side-effect of prostate cancer therapy Cancer risk higher for diabetes patients Poor glycemic control worsens risk, but insulin usage is protective, registry data suggest Mammography panned again Trastuzumab: The gift that keeps on giving Breast cancer benefits continue to grow after treatment Novel drug extends breast cancer control Kinase inhibitor looks promising in phase II trial Chemo-plus-surgery trial shows more is better Adjuvant therapy needed after surgery for local recurrence Adverse Reactions: Calcitonin and cancer risk Health Canada reviewing European recommendations that restrict use of calcitonin because of evidence suggesting an increased risk of cancer. The latest in targeted tumour therapy: Aspirin Study suggests ASA helps treat certain forms of colorectal cancer Colonoscopy: Is more frequent screening better? Study suggests average-risk men get scoped every four to six years First Previous 45 46 47 48 49 Next Last
